Tomasz Chełmicki
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 2
-
- RNA modifications and cancer 2
- RNA Research and Splicing 2
-
- interferon and immune responses 1
- Phagocytosis and Immune Regulation 1
-
- Cancer Mechanisms and Therapy 1
-
- Nitric Oxide and Endothelin Effects 1
-
- Peptidase Inhibition and Analysis 1
- Co-authors
- François DossinMathilde DuraSonia LameirasDéborah Bourc’hisLorraine BonnevilleAurélie TeissandierYves GorinKaren Block
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Tomasz Chełmicki
7 papers receiving 616 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 201
- Molecular Biology 489
- Immunology 86
- Genetics 84
- Aging 4
Countries citing papers authored by Tomasz Chełmicki
This map shows the geographic impact of Tomasz Chełmicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Chełmicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Chełmicki more than expected).
Fields of papers citing papers by Tomasz Chełmicki
This network shows the impact of papers produced by Tomasz Chełmicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Chełmicki. The network helps show where Tomasz Chełmicki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomasz Chełmicki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | m6A RNA methylation regulates the fate of endogenous retrovirusesbreakdown → | 2021 | 200 |
| 2 | 2020 | 140 | |
| 3 | 2016 | 18 | |
| 4 | 2014 | 83 | |
| 5 | 2010 | 37 | |
| 6 | 2009 | 43 | |
| 7 | 2007 | 101 |
About Tomasz Chełmicki
Tomasz Chełmicki is a scholar working on Cancer Research, Immunology and Allergy and Immunology, having authored 7 papers that have together received 622 indexed citations. Recurring topics across this work include RNA modifications and cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), RNA Research and Splicing (2 papers), interferon and immune responses (1 paper), Cancer Mechanisms and Therapy (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Phagocytosis and Immune Regulation (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Cancer Research (201 citations), Molecular Biology (489 citations) and Immunology (86 citations). Tomasz Chełmicki has collaborated with scholars based in Germany, United States and France. Frequent co-authors include François Dossin, Mathilde Dura, Sonia Lameiras, Déborah Bourc’his, Lorraine Bonneville, Aurélie Teissandier, Yves Gorin, Karen Block, Hanna E. Abboud and Édith Heard. Their work appears in journals such as Nature, Cytokine, eLife, Journal of Biological Chemistry and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.